|
Get More Information On: (ADHD) Attention Deficit Hyperactivity Disorder References Arnold, L.E. Alternative treatments for adults with attention-deficit hyperactivity disorder. Ann. N.Y. Acad. Sci. 2001 Jun; 931: 310-41. Arnold, L.E., Pinkham, S.M., Votolato, N. Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivity disorder? J. Child. Adolesc. Psychopharmacol. 2000; 10(2): 111-7. Babcock, Q., Byrne, T. Student perceptions of methylphenidate abuse at a public liberal arts college. J. Am. Coll. Health 2000 Nov; 49(3): 143-5. Bandstra, E.S., Morrow, C.E., Anthony, J.C., Accornero, V.H., Fried, P.A. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol. Teratol. 2001 Nov-Dec; 23(6): 545-59. Bekaroglu, M., Aslan, Y., Gedik, Y., Deger, O., Mocan, H., Erduran, E., Karahan, C. Relationships between serum-free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J. Child. Psychol. Psychiatry 1996; 37(2): 225-7. Berdonces, J.L. Attention deficit and infantile hyperactivity. Rev. Enferm. 2001 Jan; 24(1): 11-4. Bhagavan, H.N., Coleman, M., Coursin, D.B. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children. Pediatrics 1975; 55: 437-41. Biederman, J., Spencer, T. Non-stimulant treatments for ADHD. Eur. Child. Adolesc. Psychiatry 2000; 9(Suppl. 1): I51-9. Boris, M., Mandel, F. Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann. Allergy 1993; 72(5): 462-7. Breggin, P.R. Psychostimulants in the treatment of children diagnosed with ADHD: risks and mechanism of action. Int. J. Risk Safety Med. 1999; 12: 3-35. Burgess, J.R., Stevens, L., Zhang, W., Peck, L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 2000 Jan; 71(Suppl. 1): 327S-330S. Carlsson, M.L. On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions. Acta Psychiatr. Scand. 2000 Dec; 102(6): 401-13; erratum in Acta Psychiatr. Scand. 2001 Jul; 104(1): 80. Chabot, R.J., di Michele, F., Prichep, L., John, E.R. The clinical role of computerized EEG in the evaluation and treatment of learning and attention disorders in children and adolescents. J. Neuropsychiatry Clin. Neurosci. 2001 Spring; 13(2): 171-86. Comings, D.E., Blum, K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog. Brain Res. 2000; 126: 325-41. Crook, W.G. Can what a child eats make him dull, stupid or hyperactive? J. Learning Disabilities 1980; 13: 53-8. Davenport, T.H., Beck. J.C. Getting the attention you need. Harv. Bus. Rev. 2000 Sep-Oct; 78(5): 118-26, 200. Daviss, W.B., Bentivoglio, P., Racusin, R., Brown, K.M., Bostic, J.Q., Wiley, L. Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J. Am. Acad. Child. Adolesc. Psychiatry 2001 Mar; 40(3): 307-14. Dean, J., Morgenthaler, J.
DMAE. Smart Drugs and Nutrients 1990. Menlo Park, CA: Health Freedom
Publications. Egger, J., Carter, C.M., Graham, P.J, Gumley, D., Soothill, J.F. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet 1985 Mar 9: 540-5. Ford, J.D., Racusin, R., Ellis, C.G., Daviss, W.B., Reiser, J., Fleischer, A., Thomas, J. Child maltreatment, other trauma exposure, and posttraumatic symptomatology among children with oppositional defiant and attention deficit hyperactivity disorders. Child. Maltreat. 2000 Aug; 5(3): 205-17. Geller, B., Bolhofner, K., Craney, J.L., Williams, M., DelBello, M.P., Gundersen, K. Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J. Am. Acad. Child. Adolesc. Psychiatry 2000 Dec; 39(12): 1543-8. Girardi, N.L., Shaywitz, S.E., Shaywitz, B.A., Marchione, K., Fleischman, S.J., Jones, T.W., Tamborlane, W.V. Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder. Pediatr. Res. 1995 Oct; 38(4): 539-42. Goddard, J. Perceived passage of time: its possible relationship to attention-deficit hyperactivity disorder. Med. Hypotheses 2000 Oct; 55(4): 351-2. Hamrin, V., Bailey, K. Gabapentin and methylphenidate treatment of a preadolescent with attention deficit hyperactivity disorder and bipolar disorder. J. Child. Adolesc. Psychopharmacol. 2001 Fall; 11(3): 301-9. Jorisse, B.L., Brouns, F., Van Boxtel, M.P., Ponds, R.W., Verhey, F.R., Jolles, J., Riedel, W.J. The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr. Neurosci. 2001; 4(2): 121-34. Kaneko, M., Hoshino, Y., Hashimoto, S., Okano, T., Kumashiro, H. Hypothalamic-pituitary-adrenal axis function in children with attention-deficit hyperactivity disorder. J. Autism Dev. Disord. 1993 Mar; 23(1): 59-65. Kent, L., Green, E., Holmes, J., Thapar, A., Gill, M., Hawi, Z., Fitzgerald, M., Asherson, P., Curran, S., Mills, J., Payton, A., Craddock, N. No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder. Am. J. Med. Genet. 2001 Dec 8; 105(8): 686-9. Kidd, P.M. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Altern. Med. Rev. 2000 Oct; 5(5): 402-28. Kim, B.N., Lee, J.S., Cho, S.C., Lee, D.S. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder. Yonsei Med. J. 2001 Feb; 42(1): 19-29. Kooij, J.J., Aeckerlin, L.P., Buitelaar, J.K. Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department. Ned. Tijdschr. Geneeskd. 2001 Aug 4; 145(31): 1498-1501 (in Dutch). Kuhle, H.J., Hoch, C., Rautzenberg, P., Jansen, F. Brief video-assisted observation of visual attention, facial expression, and motor skills for diagnosis of attention deficit/hyperactivity disorder (ADHD). Prax. Kinderpsychol. Kinderpsychiatr. 2001 Oct; 50(8): 607-21 (in German). Levin, E.D., Conners, C.K., Silva, D., Canu, W., March, J. Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp. Clin. Psychopharmacol. 2001 Feb; 9(1): 83-90. Liao, F. Herbs of activating blood circulation to remove blood stasis. Clin. Hemorheol. Microcirc. 2000; 23(2-4): 127-31. Lyon, M.R., Cline, J.C., Totosy de Zepetnek, J., Shan, J.J., Pang, P., Benishin, C. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study. J. Psychiatry Neurosci. 2001 May; 26(3): 221-8. Mannuzza, S., Klein, R.G. Long-term prognosis in attention-deficit/hyperactivity disorder. Child. Adolesc. Psychiatr. Clin. N. Am. 2000 Jul; 9(3): 711-26. Michelson, D., Faries, D.,
Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F.R., Spencer, T.
Atomoxetine in the treatment of children and adolescents with
attention-deficit/hyperactivity disorder: a randomized, placebo-controlled,
dose-response study. Mitsis, E.M., Halperin, J.M., Newcorn, J.H. Serotonin and aggression in children. Curr. Psychiatry Rep. 2000 Apr; 2(2): 95-101. Munoz, K.A., Krebs-Smith, S.M., Ballard-Barbash, R., Cleveland, L.E. Food intakes of U.S. children and adolescents compared with recommendations. Pediatrics 1997 Sep; 100(3): 323-9. O'Brien, J. Mercury amalgam toxicity. Life Extension Magazine 2001 May; 7(5): 43-51. Ft. Lauderdale, FL: Life Extension Foundation. Overmeyer, S., Bullmore, E.T., Suckling, J., Simmons, A., Williams, S.C., Santosh, P.J., Taylor, E. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol. Med. 2001 Nov; 31(8): 1425-35. Paule, M.G., Rowland, A.S., Ferguson, S.A., Chelonis, J.J., Tannock, R., Swanson, J.M., Castellanos, F.X. Attention deficit/hyperactivity disorder: characteristics, interventions and models. Neurotoxicol. Teratol. 2000 Sep-Oct; 22(5): 631-51. PDR. Adderall. Physicians' Desk Reference 2002. Montvale, NJ: Medical Economics/Simon & Schuster. Ponce Alfaro, G., Rodriguez-Jimenez Caumel, R., Perez Rojo, J.A., Monasor Sanchez, R., Rubio Valladolid, G., Jimenez Arriero, M.A., Palomo Alvarez, T. Attention-deficit hyperactivity disorder and vulnerability to the development of alcoholism: use of the Wender-Utah Rating Scale for retrospective diagnostic of ADHD in the childhood of alcoholic patients. Actas Esp. Psiquiatr. 2000 Nov-Dec; 28(6): 357-66 (in Spanish). Rasmussen, P., Gillberg, C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J. Am. Acad. Child. Adolesc. Psychiatry 2000 Nov; 39(11): 1424-31. Rice, D.C. Parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys. Environ. Health Perspect. 2000 Jun; 108(Suppl. 3): 405-8. Richardson, A.J., Puri, B.K. The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukot. Essent. Fatty Acids 2000a Jul-Aug; 63(1-2): 79-87. Richardson, A.J., Puri, B.K. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002 Feb; 26(2): 233-9. Richardson, A.J., Ross, M.A. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fatty Acids 2000b Jul-Aug; 63(1-2): 1-9. Rowe, K., Rowe, K. Synthetic food coloring and behavior, a dose response effect in a double-blind, placebo controlled, repeated-measures study. J. Pediatr. 1994; 125: 691-8. Sangare, J. ADHD: making the appropriate pediatric assessment. Lippincotts Prim. Care Pract. 2000 Mar-Apr; 4(2): 193-206. Schoenthaler, S.J., Bier, I.D. The effect of vitamin-mineral supplementation on juvenile delinquency among American schoolchildren: a randomized, double-blind placebo-controlled trial. J. Altern. Complement. Med. 2000 Feb; 6(1): 7-17. Schrimshaw, S., Gordon, J.E. Effect of early marasmic malnutrition on subsequent physical and psychological development. Malnutrition, Learning and Behavior Behavoir 1968. Cambridge, MA: MIT Press. Sevulla, I., Aguiree, N. Study on the Effects of Super Blue Green Algae 1995. Managua, Nicaragua: Universidad Centro Americano. Shaffer, R.J., Jacokes, L.E., Cassily, J.F., Greenspan, S.I., Tuchman, R.F., Stemmer, P.J., Jr. Effect of interactive metronome training on children with ADHD. Am. J. Occup. Ther. 2001 Mar-Apr; 55(2): 155-62. Starobrat-Hermelin, B., Kozielec, T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnesium Res. 1997; 10(2): 149-56. Strous, R.D., Spivak, B., Yoran-Hegesh, R., Maayan, R., Averbuch, E., Kotler, M., Mester, R., Weizman, A. Analysis of neurosteroid levels in attention deficit hyperactivity disorder. Int. J. Neuropsychopharmacol. 2001 Sep; 4(3): 256-64. Sunohara, G.A., Roberts, W., Malone, M., Schachar, R.J., Tannock, R., Basile, V.S., Wigal, T., Wigal, S.B., Schuck, S., Moriarty, J., Swanson, J.M., Kennedy, J.L., Barr, C.L. Linkage of the dopamine D4 receptor gene and attention deficit/hyperactivity disorder. J. Am. Acad. Child. Adolesc. Psychiatry 2000 Dec; 39(12): 1537-42. Tantillo, M., Kesick, C.M., Hynd, G.W., Dishman, R.K. The effects of exercise on children with attention-deficit hyperactivity disorder. Med. Sci. Sports Exerc. 2002 Feb; 34(2): 203-12. Taylor, F.B., Russo, J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J. Child. Adolesc. Psychopharmacol. 2000 Winter; 10(4): 311-20. Todd, R.D., Botteron, K.N. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol. Psychiatry 2001 Aug 1; 50(3): 151-8. Torres-Duran, P.V., Miranda-Zamora, R., Paredes-Carbajal, M.C., Mascher, D., Diaz-Zagoya, J.C., Juarez-Oropeza, M.A. Spirulina maxima prevents induction of fatty liver by carbon tetrachloride in the rat. Biochem. Mol. Biol. Int. 1998; 44: 787-93. Vadiraja, B.B., Gaikwad, N.W., Madyastha, K.M. Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicity in rats. Biochem. Biophys. Res. Commun. 1998; 249: 428-31. Vastag, B. Pay attention: ritalin acts much like cocaine. JAMA 2001 Aug 22-29; 286(8): 905-6. Voigt, R.G., Llorente, A.M., Jensen, C.L., Fraley, J.K., Berretta, M.C., Heird, W.C. A randomized, double-blind, placebo-controlled trial of docosahexanoic acid supplementation in children with attention-deficit/hyperactivity disorder. J. Pediatr. 2001; 39: 189. Wender, E.H., Solanto, M.V. Effects of sugar on aggressive and inattentive behavior in children with attention deficit disorder with hyperactivity and normal children. Pediatrics 1991 Nov; 88(5): 960-6. Wender, P.H., Wolf, L.E., Wasserstein, J. Adults with ADHD. An overview. Ann. N.Y. Acad. Sci. 2001 Jun; 931: 1-16. Wolraich, M.L., Lindgren, S.D., Stumbo, P.J., Stegink, L.D., Appelbaum, M.I., Kiritsy, M.C. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children. N. Engl. J. Med. 1994; 330: 301. Yeo, R.A., Hill, D., Campbell, R., Vigil, J., Brooks, W.M. Developmental instability and working memory ability in children: a magnetic resonance spectroscopy investigation. Dev. Neuropsychol. 2000; 17(2): 143-59. Zito, J.M., Safer, D.J., dosReis, S., Gardner, J.F., Boles, M., Lynch, F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000; 283: 1025-30. Get More Information On:
|